Varda blocked from bringing its capsule back to Earth by FAA
Varda has been forced to delay the first return of its capsule from space, loaded with a drug designed to treat HIV/AIDS that can only be manufactured in weightlessness, because the FAA has so far refused to issue “a re-entry license,” a new regulatory power grab the FAA instituted two years ago supposedly to “streamline the launch and reentry licensing process.”
This new language, which I was unaware of and know of no Congressional act approving it, has done exactly the opposite.
A key issue, he said, is that Varda is the first to seek a reentry license under new FAA regulations known as Part 450. Those regulations were enacted by the FAA more than two years ago to streamline the launch and reentry licensing process.
…For the commercial launch industry, the Part 450 regulations have become an area of concern. Only a handful of Part 450 launch licenses have been issued to date as the FAA begins a transition to the new regulations, but those licenses have taken longer to complete than expected, in some cases missing a 180-day statutory deadline. Industry officials raised the issue at a July 13 hearing of the House Science Committee and at a July 11 meeting of an FAA advisory group, the Commercial Space Transportation Advisory Committee. [emphasis mine]
The highlighted language says it all. It also suggests these new regulations, apparently written by the FAA and not Congress, might be contributing to the delays being experienced by SpaceX in its attempt to do test launches of its Starship/Superheavy rocket.
Varda is presently hoping to return the capsule in mid-August. It had begun this re-entry licensing process in early 2021 — more than two years ago — and still does not have that approval. Its business plan is to make money by manufacturing things in weightlessness that can’t be made on Earth — such as this HIV drug — and returning those items to Earth for sale.
Such a plan can’t work if the federal administrative state stands in the way.
Varda has been forced to delay the first return of its capsule from space, loaded with a drug designed to treat HIV/AIDS that can only be manufactured in weightlessness, because the FAA has so far refused to issue “a re-entry license,” a new regulatory power grab the FAA instituted two years ago supposedly to “streamline the launch and reentry licensing process.”
This new language, which I was unaware of and know of no Congressional act approving it, has done exactly the opposite.
A key issue, he said, is that Varda is the first to seek a reentry license under new FAA regulations known as Part 450. Those regulations were enacted by the FAA more than two years ago to streamline the launch and reentry licensing process.
…For the commercial launch industry, the Part 450 regulations have become an area of concern. Only a handful of Part 450 launch licenses have been issued to date as the FAA begins a transition to the new regulations, but those licenses have taken longer to complete than expected, in some cases missing a 180-day statutory deadline. Industry officials raised the issue at a July 13 hearing of the House Science Committee and at a July 11 meeting of an FAA advisory group, the Commercial Space Transportation Advisory Committee. [emphasis mine]
The highlighted language says it all. It also suggests these new regulations, apparently written by the FAA and not Congress, might be contributing to the delays being experienced by SpaceX in its attempt to do test launches of its Starship/Superheavy rocket.
Varda is presently hoping to return the capsule in mid-August. It had begun this re-entry licensing process in early 2021 — more than two years ago — and still does not have that approval. Its business plan is to make money by manufacturing things in weightlessness that can’t be made on Earth — such as this HIV drug — and returning those items to Earth for sale.
Such a plan can’t work if the federal administrative state stands in the way.